Article Details

Encoded Therapeutics bags $104M to propel 'precision gene therapy' for Dravet syndrome

Retrieved on: 2019-06-25 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

Encoded Therapeutics bags $104M to propel 'precision gene therapy' for Dravet syndrome. View article details on hiswai:

Excerpt

<div>... ARCH Venture Partners, Matrix Capital Management, Illumina Ventures and Altitude Life Science Ventures, as well as newcomers <b>Menlo Ventures</b>, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up